Home > Compound List > Compound details
MFCD11506498 molecular structure
click picture or here to close

1-(cyclohexyloxy)-3-(piperazin-1-yl)propan-2-ol dihydrochloride

ChemBase ID: 30714
Molecular Formular: C13H28Cl2N2O2
Molecular Mass: 315.27962
Monoisotopic Mass: 314.15278351
SMILES and InChIs

SMILES:
N1(CC(COC2CCCCC2)O)CCNCC1.Cl.Cl
Canonical SMILES:
OC(CN1CCNCC1)COC1CCCCC1.Cl.Cl
InChI:
InChI=1S/C13H26N2O2.2ClH/c16-12(10-15-8-6-14-7-9-15)11-17-13-4-2-1-3-5-13;;/h12-14,16H,1-11H2;2*1H
InChIKey:
HMVIZIIUVPCYIO-UHFFFAOYSA-N

Cite this record

CBID:30714 http://www.chembase.cn/molecule-30714.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
1-(cyclohexyloxy)-3-(piperazin-1-yl)propan-2-ol dihydrochloride
IUPAC Traditional name
1-(cyclohexyloxy)-3-(piperazin-1-yl)propan-2-ol dihydrochloride
Synonyms
1-Cyclohexyloxy-3-piperazin-1-yl-propan-2-ol dihydrochloride
MDL Number
MFCD11506498
PubChem SID
160994021
PubChem CID
46736443

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price
Matrix Scientific
033373 external link Add to cart Please log in.
Data Source Data ID
PubChem 46736443 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 14.097355  H Acceptors
H Donor LogD (pH = 5.5) -2.4261396 
LogD (pH = 7.4) -1.0873091  Log P 0.7762012 
Molar Refractivity 68.7637 cm3 Polarizability 27.579607 Å3
Polar Surface Area 44.73 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Safety Information Bioassay(PubChem)
Storage Warning
IRRITANT expand Show data source
MSDS Link
Download expand Show data source
TSCA Listed
false expand Show data source

DETAILS

DETAILS

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle